299 related articles for article (PubMed ID: 9104558)
21. The pharmacology and pharmacokinetics of high-dose methocarbamol in horses.
Muir WW; Sams RA; Ashcraft S
Equine Vet J Suppl; 1992 Feb; (11):41-4. PubMed ID: 9109959
[TBL] [Abstract][Full Text] [Related]
22. Single dose pharmacokinetics of pleconaril in neonates. Pediatric Pharmacology Research Unit Network.
Kearns GL; Bradley JS; Jacobs RF; Capparelli EV; James LP; Johnson KM; Abdel-Rahman SM
Pediatr Infect Dis J; 2000 Sep; 19(9):833-9. PubMed ID: 11001105
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of influenza virus replication by plant-derived isoquercetin.
Kim Y; Narayanan S; Chang KO
Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of intravenous and oral administration of enrofloxacin to the late-term pregnant and non-pregnant mares.
Ellerbrock RE; Curcio BR; Zhong L; Honoroto J; Wilkins P; Lima FS; Giguere S; Canisso IF
Equine Vet J; 2020 May; 52(3):464-470. PubMed ID: 31483886
[TBL] [Abstract][Full Text] [Related]
25. Anti-influenza A virus activity of amantadine hydrochloride and rimantadine hydrochloride in ferret tracheal ciliated epithelium.
Burlington DB; Meiklejohn G; Mostow SR
Antimicrob Agents Chemother; 1982 May; 21(5):794-9. PubMed ID: 7103458
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of oral amantadine in greyhound dogs.
Norkus C; Rankin D; Warner M; KuKanich B
J Vet Pharmacol Ther; 2015 Jun; 38(3):305-8. PubMed ID: 25427541
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats.
Stecklair KP; Hamburger DR; Egorin MJ; Parise RA; Covey JM; Eiseman JL
Cancer Chemother Pharmacol; 2001 Nov; 48(5):375-82. PubMed ID: 11761455
[TBL] [Abstract][Full Text] [Related]
28. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of tolfenamic acid in the horse.
Jaussaud P; Guieu D; Bellon C; Barbier B; Lhopital MC; Sechet R; Courtot D; Toutain PL
Equine Vet J Suppl; 1992 Feb; (11):69-72. PubMed ID: 9109966
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of a single intravenous dose of the neuraminidase inhibitor peramivir in the treatment of equine influenza.
Yamanaka T; Bannai H; Nemoto M; Tsujimura K; Kondo T; Muranaka M; Hobo S; Minamijima YH; Yamada M; Matsumura T
Vet J; 2012 Aug; 193(2):358-62. PubMed ID: 22326934
[TBL] [Abstract][Full Text] [Related]
31. Respiratory responses of mature horses to intravenous lobeline bolus.
Marlin DJ; Roberts CA; Schroter RC; Lekeux P
Equine Vet J; 2000 May; 32(3):200-7. PubMed ID: 10836474
[TBL] [Abstract][Full Text] [Related]
32. Quantitative determination of amantadine in human plasma by liquid chromatography-mass spectrometry and the application in a bioequivalence study.
Wang P; Liang YZ; Chen BM; Zhou N; Yi LZ; Yu Y; Yi ZB
J Pharm Biomed Anal; 2007 Mar; 43(4):1519-25. PubMed ID: 17156962
[TBL] [Abstract][Full Text] [Related]
33. Phenylbutazone in the horse: a review.
Tobin T; Chay S; Kamerling S; Woods WE; Weckman TJ; Blake JW; Lees P
J Vet Pharmacol Ther; 1986 Mar; 9(1):1-25. PubMed ID: 3517382
[TBL] [Abstract][Full Text] [Related]
34. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
Schnabel LV; Papich MG; Divers TJ; Altier C; Aprea MS; McCarrel TM; Fortier LA
Equine Vet J; 2012 Jul; 44(4):453-8. PubMed ID: 21950341
[TBL] [Abstract][Full Text] [Related]
36. I-adamantanamine hydrochloride prophylaxis for experimentally induced A/equine 2 influenza virus infection.
Bryans JT; Zent WW; Grunert RR; Boughton DC
Nature; 1966 Dec; 212(5070):1542-4. PubMed ID: 21105501
[No Abstract] [Full Text] [Related]
37. Simultaneous determination of amantadine and rimantadine by HPLC in rat plasma with pre-column derivatization and fluorescence detection for pharmacokinetic studies.
Higashi Y; Uemori I; Fujii Y
Biomed Chromatogr; 2005 Nov; 19(9):655-62. PubMed ID: 15803448
[TBL] [Abstract][Full Text] [Related]
38. Disposition, behavioural and physiological effects of escalating doses of intravenously administered fentanyl to young foals.
Knych HK; Steffey EP; Casbeer HC; Mitchell MM
Equine Vet J; 2015 Sep; 47(5):592-8. PubMed ID: 24978306
[TBL] [Abstract][Full Text] [Related]
39. The toxicokinetics of cyanide and mandelonitrile in the horse and their relevance to the mare reproductive loss syndrome.
Dirikolu L; Hughes C; Harkins D; Boyles J; Bosken J; Lehner F; Troppmann A; McDowell K; Tobin T; Sebastian MM; Harrison L; Crutchfield J; Baskin SI; Fitzgerald TD
Toxicol Mech Methods; 2003; 13(3):199-211. PubMed ID: 20021160
[TBL] [Abstract][Full Text] [Related]
40. The relative potencies of anti-influenza compounds.
Tisdale M; Bauer DJ
Ann N Y Acad Sci; 1977 Mar; 284():254-63. PubMed ID: 280137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
